Apellis Pharmaceuticals, Inc. (NASDAQ:APLS): When Will It Breakeven?

Simply Wall StDec 24 18:42

Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

BenzingaDec 17 21:04

This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

BenzingaDec 17 21:00

Apellis Pharmaceuticals Price Target Announced at $36.00/Share by Goldman Sachs

Dow JonesDec 17 20:23 · Ratings

Goldman Sachs Downgrades Apellis Pharmaceuticals(APLS.US) to Hold Rating

Futu NewsDec 17 18:34 · Ratings

Goldman Sachs Downgrades Apellis Pharmaceuticals (APLS) to a Hold

TipRanksDec 17 18:15 · Ratings